94 related articles for article (PubMed ID: 15800942)
1. Migration-stimulating factor displays HEXXH-dependent catalytic activity important for promoting tumor cell migration.
Houard X; Germain S; Gervais M; Michaud A; van den Brûle F; Foidart JM; Noël A; Monnot C; Corvol P
Int J Cancer; 2005 Sep; 116(3):378-84. PubMed ID: 15800942
[TBL] [Abstract][Full Text] [Related]
2. Migration Stimulating Factor (MSF): Its Role in the Tumour Microenvironment.
Schor AM; Woolston AM; Kankova K; Harada K; Aljorani LE; Perrier S; Felts PA; Keatch RP; Schor SL
Adv Exp Med Biol; 2021; 1329():351-397. PubMed ID: 34664248
[TBL] [Abstract][Full Text] [Related]
3. Migration-stimulating factor (MSF) is over-expressed in non-small cell lung cancer and promotes cell migration and invasion in A549 cells over-expressing MSF.
Deng X; Ma Q; Zhang B; Jiang H; Zhang Z; Wang Y
Exp Cell Res; 2013 Oct; 319(17):2545-53. PubMed ID: 23791940
[TBL] [Abstract][Full Text] [Related]
4. Migration-stimulating factor: a genetically truncated onco-fetal fibronectin isoform expressed by carcinoma and tumor-associated stromal cells.
Schor SL; Ellis IR; Jones SJ; Baillie R; Seneviratne K; Clausen J; Motegi K; Vojtesek B; Kankova K; Furrie E; Sales MJ; Schor AM; Kay RA
Cancer Res; 2003 Dec; 63(24):8827-36. PubMed ID: 14695199
[TBL] [Abstract][Full Text] [Related]
5. Multi-factorial modulation of IGD motogenic potential in MSF (migration stimulating factor).
Ellis IR; Jones SJ; Staunton D; Vakonakis I; Norman DG; Potts JR; Milner CM; Meenan NA; Raibaud S; Ohea G; Schor AM; Schor SL
Exp Cell Res; 2010 Sep; 316(15):2465-76. PubMed ID: 20403349
[TBL] [Abstract][Full Text] [Related]
6. Binding of MMP-9-degraded fibronectin to β6 integrin promotes invasion via the FAK-Src-related Erk1/2 and PI3K/Akt/Smad-1/5/8 pathways in breast cancer.
Li W; Liu Z; Zhao C; Zhai L
Oncol Rep; 2015 Sep; 34(3):1345-52. PubMed ID: 26134759
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis and tumour progression: migration-stimulating factor as a novel target for clinical intervention.
Schor AM; Schor SL
Eye (Lond); 2010 Mar; 24(3):450-8. PubMed ID: 20019766
[TBL] [Abstract][Full Text] [Related]
8. Fibronectin degradation by human gastric carcinoma cell lines and its associated proteases in relation to stromal invasion in nude mice.
Wakabayashi H; Kawaguchi T
Invasion Metastasis; 1992; 12(5-6):284-300. PubMed ID: 1298740
[TBL] [Abstract][Full Text] [Related]
9. Matrix assembly induction and cell migration and invasion inhibition by a 13-amino acid fibronectin peptide.
Colombi M; Zoppi N; De Petro G; Marchina E; Gardella R; Tavian D; Ferraboli S; Barlati S
J Biol Chem; 2003 Apr; 278(16):14346-55. PubMed ID: 12582155
[TBL] [Abstract][Full Text] [Related]
10. Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism.
Wijelath ES; Rahman S; Namekata M; Murray J; Nishimura T; Mostafavi-Pour Z; Patel Y; Suda Y; Humphries MJ; Sobel M
Circ Res; 2006 Oct; 99(8):853-60. PubMed ID: 17008606
[TBL] [Abstract][Full Text] [Related]
11. Migration stimulating factor (MSF): its structure, mode of action and possible function in health and disease.
Schor SL; Grey AM; Ellis I; Schor AM; Coles B; Murphy R
Symp Soc Exp Biol; 1993; 47():235-51. PubMed ID: 8165568
[TBL] [Abstract][Full Text] [Related]
12. Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion.
Bemis LT; Schedin P
Cancer Res; 2000 Jul; 60(13):3414-8. PubMed ID: 10910049
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity amongst fibroblasts in the production of migration stimulating factor (MSF): implications for cancer pathogenesis.
Schor SL; Grey AM; Picardo M; Schor AM; Howell A; Ellis I; Rushton G
EXS; 1991; 59():127-46. PubMed ID: 1833226
[TBL] [Abstract][Full Text] [Related]
14. VEGF(165) requires extracellular matrix components to induce mitogenic effects and migratory response in breast cancer cells.
Miralem T; Steinberg R; Price D; Avraham H
Oncogene; 2001 Sep; 20(39):5511-24. PubMed ID: 11571649
[TBL] [Abstract][Full Text] [Related]
15. Role of the heparin-binding domain of chimeric peptides derived from fibronectin in cell spreading and motility.
Yoneda J; Saiki I; Igarashi Y; Kobayashi H; Fujii H; Ishizaki Y; Kimizuka F; Kato I; Azuma I
Exp Cell Res; 1995 Mar; 217(1):169-79. PubMed ID: 7867715
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer cells alter the dynamics of stromal fibronectin-collagen interactions.
Wang K; Wu F; Seo BR; Fischbach C; Chen W; Hsu L; Gourdon D
Matrix Biol; 2017 Jul; 60-61():86-95. PubMed ID: 27503584
[TBL] [Abstract][Full Text] [Related]
17. The interaction of tenascin-C with fibronectin modulates the migration and specific metalloprotease activity in human mesothelioma cell lines of different histotype.
Giuffrida A; Scarpa S; Birarelli P; Modesti A
Int J Oncol; 2004 Sep; 25(3):745-50. PubMed ID: 15289878
[TBL] [Abstract][Full Text] [Related]
18. Detection of migration stimulating activity in wound fluid.
Picardo M; Grey AM; McGurk M; Ellis I; Schor SL
Exp Mol Pathol; 1992 Aug; 57(1):8-21. PubMed ID: 1397194
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic and genetic alterations in mammary stroma: implications for tumour progression.
Schor SL; Schor AM
Breast Cancer Res; 2001; 3(6):373-9. PubMed ID: 11737888
[TBL] [Abstract][Full Text] [Related]
20. Liberation of an N-terminal proline-rich peptide from the cryptic proteinase of fibronectin by auto-proteolysis.
Pagano M; Clodic G; Bolbach G; Michiel M; Haddag S; Reboud-Ravaux M
Arch Biochem Biophys; 2008 Nov; 479(2):158-62. PubMed ID: 18789884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
